News AZ partners with Aptar on kidney disease-detecting AI AstraZeneca has turned to another digital health partner to support its aspirations in chronic kidney disease (CKD).
News UK trumpets £1bn investment plan from BioNTech BioNTech has said it will commit up to £1bn in investment in the UK over the next decade, in what has been described as a "template" for the sector.
News 'Trust gap' is holding back AI in healthcare The potential for AI to help tackle bottlenecks in healthcare is being held back by patient scepticism and doctor concerns about bias and liability.
News Could an AI for biological age guide cancer treatment? Researchers have developed an AI that could help doctors predict a patient's chance of surviving cancer – and potentially guide treatment decisions.
News AI trained on NHS data 'may predict ill health in advance' An AI model is being piloted at a national scale for the first time, but will it be able to predict future health risks reliably?
News Lilly forges a $415m ALS alliance with UK biotech Alchemab Eli Lilly has added another candidate to a growing pipeline of therapies for ALS, tapping Alchemab for an antibody sourced from 'resilient' patients.
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
